申请人:STARPHARMA PTY LTD.
公开号:US20160220689A1
公开(公告)日:2016-08-04
A macromolecule comprising a dendrimer having surface amino groups to which at least one platinum-containing moiety is attached is provided. The macromolecule may have a plurality of platinum-containing moieties attached to the surface amino groups. Alternatively, the macromolecule may comprise a dendrimer having surface amino groups to which at least two different moieties are attached, a first moiety being a platinum-containing moiety and the second moiety being a pharmacokinetic modifying agent or targeting agent. Pharmaceutical compositions comprising the macromolecules and uses of the macromolecules for treating or suppressing the growth of a cancer is also described.
本发明提供了一种大分子,包括具有表面氨基团的树状分子,至少一个含铂基团附着于其上。该大分子可以具有多个附着在表面氨基团上的含铂基团。或者,该大分子可以包括具有表面氨基团的树状分子,至少附着有两种不同的基团,第一种基团是含铂基团,第二种基团是药物动力学修饰剂或靶向剂。还描述了包括该大分子的制药组合物以及使用该大分子治疗或抑制癌症生长的用途。